Posts

Showing posts with the label discovery

Conference on Semantics in Healthcare and Life Sciences (CSHALS)

C SHALS is the premier annual event focused on the use of semantic technologies in the pharmaceutical industry, including hospitals/healthcare institutions and academic research labs. Rather than a Semantic Web conference, CSHALS focuses on specific applications of semantic technologies. Attendees will gain a better understanding of where the field is headed and be prepared to advance with the field. Themes of past CSHALS conferences: Clinical Information Management Discovery Information Integration Integrated Healthcare and Semantics in Electronic Health Records Translational Medicine / Safety Search and Document Management/Business Intelligence/Text Mining Text Mining/ Information Extraction For further details visit   Share |

Pfizer Postdoctoral Program in Neuroscience

Pfizer Neuroscience Postdoctoral Fellowship Program www.pfizerneuroscience.com Based in scenic Groton, Connecticut, the Pfizer Neuroscience Fellowship Program provides an unparalled opportunity for young scientists interested in understanding brain disorders and translating knowledge into innovative medicines. We seek motivated and enthusiastic individuals with a demonstrated track record in basic or translational neuroscience interested in pursuing an academic-style postdoc in an industry setting. Successful candidates will come from a range of backgrounds including molecular/cellular biology, protein biochemistry, in vitro and in vivo electrophysiology, imaging, systems neuroscience, animal models, and behavioral/cognitive neuroscience. At Pfizer, there are extensive programs in molecular/cellular neuroscience, synapse biology, and pharmacology. Moreover, there is a vibrant in vivo electrophysiology program for cognition, extensive behavioral models, imaging platf...

XTractor Premium surpasses 200,000 mark of Expert Annotated PubMed Facts

Indian Life Sciences Informatics Company, Molecular Connections announced today, that their XTractor Premium platform surpasses 200,000 "Expert" annotated facts from PubMed. XTractor Premium – is a platform for discovery, analysis and modeling of published biomedical facts. The application also comes with - XTractor Premium Knowledgebase - the only knowledgebase, which provides " Expert " annotated facts from PubMed on a daily basis. The XTractor Premium Knowledgebase now has more than 202,847 relationships on proteins, drugs, biological process and diseases and is ever growing with more than 600 relationships being added every single day. XTractor provides manually categorized updates on the latest published facts from PubMed for more than 20 categories which include : Biomarkers, clinical trials, dosage, pathways, toxicology, RNAi studies, mutations, knockouts, diseases mechanisms, protein- drug relationships and much more. Expert Annotated Facts make XTractor Pr...

The future of biocuration

Blogging about curation in the past several issues have been discussed but here is something very critical. To thrive, the field that links biologists and their data urgently needs structure, recognition and support. Biocuration , the activity of organizing, representing and making biological information accessible to both humans and computers, has become an essential part of biological discovery and biomedical research. But curation increasingly lags behind data generation in funding, development and recognition. Three urgent actions to advance this key field. First, authors, journals and curators should immediately begin to work together to facilitate the exchange of data between journal publications and databases. Second, in the next five years, curators, researchers and university administrations should develop an accepted recognition structure to facilitate community-based curation efforts . Third, curators, researchers, academic institutions and funding agencies should, in the ...

Productivity tools-Simulation Software Selected as Application of Choice by Premier Pharmaceutical Company

A leading provider of software for pharmaceutical discovery and development, today announced that the pharmacokinetics , dynamics, and metabolism science board at a top three pharmaceutical company named its software an "application of choice." As pharmaceutical companies face a significant number of patent expirations in the near future, there is a need to become more aggressive in research and development to fill the pipeline, sometimes with reduced R&D staff. Productivity tools in the field of pharmacokinectics , ADMET , chemical data visualization and analysis , etc. that leverage the expertise of the industry's scientific teams. It is believed that the difficulties facing some parts of the pharmaceutical industry will result in greater use of such tools as managers realize that the savings in time and money that can be achieved through their application vastly exceeds the cost of obtaining and learning to use them.